(-)-Coclaurine hydrochloride

CAS No. 3422-42-2

(-)-Coclaurine hydrochloride( (-)-Coclaurine hydrochloride (486-39-5 Free base) )

Catalog No. M29120 CAS No. 3422-42-2

(-)-Coclaurine hydrochloride is an antagonist of nAChRs isolated from Sarcopetalum harveyanum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 393 Get Quote
10MG 581 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG 1674 Get Quote
500MG 3348 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (-)-Coclaurine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    (-)-Coclaurine hydrochloride is an antagonist of nAChRs isolated from Sarcopetalum harveyanum.
  • Description
    (-)-Coclaurine hydrochloride is an antagonist of nAChRs isolated from Sarcopetalum harveyanum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (-)-Coclaurine hydrochloride (486-39-5 Free base)
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3422-42-2
  • Formula Weight
    321.8
  • Molecular Formula
    C17H20ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@H]1C=2C(=CC(OC)=C(O)C2)CCN1)C3=CC=C(O)C=C3.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GAT107

    GAT107 is a novel and potent α7 nicotinic cholinergic receptor modifier agonist and modulator with anti-inflammatory activity that reverses injury perception in a mouse model of neuropathic pain.

  • SIB 1553A

    SIB 1553A is an orally available and selective agonist of nicotinic acetylcholine receptors (nAChRs), which are subtype-selective ligands for nicotinic acetylcholine receptors.

  • Mitotan

    Mitotane(2,4′-DDD), an isomer of DDD and derivative of DDT, is an antineoplastic medication used in the treatment of adrenocortical carcinoma.